Arkadios Wealth Advisors’s Mustang Bio MBIO Stock Holding History

Arkadios Wealth Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13	Closed	-$33K	–	1997
2021 Q1	$33K	Sell	13 -24	-65%	-$71.3K	0.01%	812
2020 Q4	$105K	Buy	+37	New	+$88.4K	0.02%	427

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arkadios Wealth Advisors's MBIO Position: Q2 2021 in Review

Arkadios Wealth Advisors sold out of Mustang Bio (MBIO) in Q2 2021, closing a stake of 13 shares — an estimated $33K sold.

Arkadios Wealth Advisors first reported a position in MBIO in Q4 2020 and held it in 2 quarters. The position peaked at $105K in Q4 2020. 92 funds tracked by Wall St. Rank hold MBIO as of Q2 2021.

Arkadios Wealth Advisors reported no remaining Mustang Bio position as of Q2 2021 after selling out during the quarter.
Arkadios Wealth Advisors sold 13 Mustang Bio shares in Q2 2021, an estimated $33K.
Arkadios Wealth Advisors first reported a position in Mustang Bio in Q4 2020 and held it in 2 quarters.
Arkadios Wealth Advisors's Mustang Bio position peaked at $105K in Q4 2020.
92 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.